Enteral Nutrition Combined with Improved-Sijunzi Decoction Shows Positive Effect in Precachexia Cancer Patients: A Retrospective Analysis
Open Access
- 22 September 2021
- journal article
- research article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-8
- https://doi.org/10.1155/2021/7357521
Abstract
Background. Cancer has been considered as the leading cause of death in the world. In patients with cancer, up to 80% display a cachectic period after diagnosis. Cachexia is known to have a negative impact on function, treatment tolerance, higher rates of hospitalizations, and mortality. Anorexia is often used as a warning sign of precachexia. Long-term anorexia may lead to malnutrition and, then, accelerate the occurrence of cachexia. A safe and effective treatment, which can both improve appetite and assist nutritional support for precachexia cancer patients shows its particular important role. Methods. A retrospective analysis comparing the different therapeutic effects on precachexia cancer patients with anorexia-malnutrition. We recorded 46 patients with the improved-Sijunzi decoction combined with enteral nutrition emulsion (ISJZ group) and 35 patients with single enteral nutrition emulsion (SEN group). The different therapeutic effects of the two groups were observed by recording indicators before and 2 weeks after treatment, including patient-generated subjective global assessment score, quality of life score, Karnofsky performance status scale, Eastern cooperative oncology group scale standard and traditional Chinese medicine syndrome, daily total dietary intake, red blood cells, hemoglobin, prealbumin, albumin, total protein cholinesterase, C-reactive protein, leukocytes, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, urea nitrogen, and creatinine. Results. ISJZ group exhibited prominent improvement of traditional Chinese medicine syndrome (TCMS), nutritional condition, and quality of life compared with the SEN group (QOL: , PG-SGA: , dietary intake:Funding Information
- Tianjin Medical University (1913)
This publication has 40 references indexed in Scilit:
- Cachexia as a major public health problem: frequent, costly, and deadlyJournal of Cachexia, Sarcopenia and Muscle, 2013
- Megestrol acetate for treatment of anorexia-cachexia syndromeEmergencias, 2013
- Prealbumin is a more sensitive marker than albumin to assess the nutritional status in patients undergoing radiotherapy for head and neck cancerContemporary Oncology, 2013
- Clinical practice guideline of Chinese medicine for chronic gastritisChinese Journal of Integrated Medicine, 2012
- Quality of Life Trajectory in Patients with Advanced Cancer during the Last Year of LifeJournal of Palliative Medicine, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- The cachexia score (CASCO): a new tool for staging cachectic cancer patientsJournal of Cachexia, Sarcopenia and Muscle, 2011
- Management of weight loss and anorexiaAnnals of Oncology, 2008
- Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations—A Study by the Steering Committee of the European Association for Palliative CareJournal of Clinical Oncology, 2005
- Therapy Insight: cancer anorexia–cachexia syndrome—when all you can eat is yourselfNature Clinical Practice Oncology, 2005